Related references
Note: Only part of the references are listed.Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
Sameer S. Kadri et al.
LANCET INFECTIOUS DISEASES (2021)
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?
Maria Milagro Montero et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospital
A. Aryee et al.
EPIDEMIOLOGY AND INFECTION (2020)
Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors
Alejandro Callejas-Diaz et al.
MEDICINA CLINICA (2019)
Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017
Changseung Liu et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection
Chia-Hung Yo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
E. Matuschek et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections
Nattawan Palavutitotai et al.
PLOS ONE (2018)
Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis
Sanjay Merchant et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Gowri Raman et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Health care-associated infections - an overview
Mainul Haque et al.
INFECTION AND DRUG RESISTANCE (2018)
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
Chia-Hsin Lee et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2017)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections
Carmen Pena et al.
CLINICAL INFECTIOUS DISEASES (2015)
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Youn Jeong Kim et al.
BMC INFECTIOUS DISEASES (2014)
Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome
Su Jin Jeong et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections
G. Samonis et al.
INFECTION (2014)
Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Dilip Nathwani et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2014)
Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy
Felipe F. Tuon et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on Outcome
Eun-Jeong Joo et al.
MICROBIAL DRUG RESISTANCE (2011)
Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection
M. D. Parkins et al.
INFECTION (2010)
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections
Cristina Suarez et al.
JOURNAL OF INFECTION (2009)
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
V Aloush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Share Paper
